• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
3,4-Dihydroxyphenyl Ethanol

3,4-Dihydroxyphenyl Ethanol

Product ID D3431
Cas No. 10597-60-1
Purity ≥95%
Product Unit SizeCostQuantityStock
10 mg $118.00 In stock
25 mg $225.00 In stock
100 mg $775.00 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

3,4-Dihydroxyphenol ethanol, also known as 3-hydroxytyrosol, is a polyphenol originally found in olive oil. 3-Hydroxytyrosol exhibits antioxidative, anti-inflammatory, anti-hyperlipidemic, anti-diabetic, anti-platelet, and anticancer chemotherapeutic activities. In brain slices undergoing hypoxia and reoxygenation, 3-hydroxytyrosol increases radical scavenging and glutathione activity and decreases lipid peroxidation and expression of prostaglandin E2 (PGE2) and IL-1β. 3-Hydroxytyrosol also decreases expression of prostaglandin E2 (PGE2), matrix metalloproteinase 9 (MMP9), and COX-2 through inhibition of PKC activation and NF-κB translocation. In animal models of diabetes, 3-hydroxytyrosol inhibits SREBP/Fas signaling to decrease lipid deposits and inhibits mitochondrial apoptosis, resulting in decreases in fasting glucose, serum lipid levels, and lipid oxidation. In whole blood and plasma, this compound inhibits platelet aggregation, inhibiting production of thromboxane B2, TNF-α, and leukocyte 6-keto-PGF1. Additionally, 3-hydroxytyrosol inhibits proliferation of cholangiocarcinoma cells in vitro and inhibits tumor growth of xenografts in vivo.

Product Info

Cas No.

10597-60-1

Purity

≥95%

Formula

C8H10O3

Formula Wt.

154.16

Chemical Name

2-(3,4-Dihydroxyphenyl)ethyl alcohol

IUPAC Name

4-(2-hydroxyethyl)benzene-1,2-diol

Synonym

3-Hydroxytyrosol

Solubility

Freely soluble in organic solvents. Slightly soluble in water (5 g/100 ml) at 25 oC.

Appearance

Light yellow viscous liquid

Shipping and Storage

Store Temp

4°C

Ship Temp

Ambient

Downloads

MSDS

D3431 MSDS PDF

Info Sheet

D3431 Info Sheet PDF

References

Garcia-Molina G, Peters E, Palmeri R, et al. Enzymatic synthesis of hydroxytyrosol from oleuropein for valorization of an agricultural waste. Bioengineered. 2024 Dec;15(1):2396647. PMID: 39235136.

Scoditti E, Nestola A, Massaro M, et al. Hydroxytyrosol suppresses MMP-9 and COX-2 activity and expression in activated human monocytes via PKCα and PKCβ1 inhibition. Atherosclerosis. 2014 Jan;232(1):17-24. PMID: 24401212.

Cao K, Xu J, Zou X, et al. Hydroxytyrosol prevents diet-induced metabolic syndrome and attenuates mitochondrial abnormalities in obese mice. Free Radic Biol Med. 2013 Dec 6;67C:396-407. PMID: 24316371.

Li S, Han Z, Ma Y, et al. Hydroxytyrosol inhibits cholangiocarcinoma tumor growth: An in vivo and in vitro study. Oncol Rep. 2014 Jan;31(1):145-52. PMID: 24247752.

Cabrerizo S, De La Cruz JP, López-Villodres JA, et al. Role of the inhibition of oxidative stress and inflammatory mediators in the neuroprotective effects of hydroxytyrosol in rat brain slices subjected to hypoxia reoxygenation. J Nutr Biochem. 2013 Dec;24(12):2152-7. PMID: 24231104.

Correa JA, López-Villodres JA, Asensi R, et al. Virgin olive oil polyphenol hydroxytyrosol acetate inhibits in vitro platelet aggregation in human whole blood: comparison with hydroxytyrosol and acetylsalicylic acid. Br J Nutr. 2009 Apr;101(8):1157-64. PMID: 18775097.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • E6470

    Eprinomectin

    Semi-synthetic avermectin; GABA potentiator.

    ≥45%
  • T0077

    Transactivator of Transcription Peptide (2-4)

    Peptide, contains two cell-penetrating sequence...

    ≥95%
  • D0005

    Dabrafenib Mesylate

    B-Raf and c-Raf inhibitor.

    ≥98%
  • L8008

    D-Luciferin, firefly, Free Acid

    Heterocyclic light-emitting compound, natural l...

    ≥98%
  • T7037

    Triptorelin Acetate

    Peptide, GnRH analog.

    ≥95%
  • A6934

    Aristolochic Acid C

    Found in Aristolochia and Radix; potential PLA2...

    ≥94%
  • C281006

    Chaetocin

    Chaetocin is naturally produced by Chaetomium s...

    ≥98%
  • B1640

    Benzydamine Hydrochloride

    NSAID; PG synthetase inhibitor.

    ≥98%
  • V3326

    Virginiamycin S1

    Macrolide antibiotic; peptidyl transferase inhi...

    ≥99%
  • G1855

    Gentiopicroside

    Secoiridoid glycoside found in Gentiana and Cep...

    ≥95%
  • D3261

    Dipropyl Disulfide

    Organosulfide found in Allium; cholesterol synt...

    ≥99%
  • C2945

    Chlorophyllin Sodium-Copper Salt

    Semi-synthetic derivative of chlorophyll; food ...

    USP 28
  • P5878

    Potassium Canrenoate

    Aldosterone antagonist.

    ≥98%
  • G8101

    Guaifenesin

    Expectorant.

    ≥98%
  • B3458

    Biopterin

    Endogenous pterin coenzyme required for release...

    ≥98%
  • D6957

    Droloxifene

    Triphenylthylene, tamoxifen analog; SERM.

    ≥98%
  • C600000

    CP 55940

    Non-selective CB receptor agonist.

    ≥97%
  • L1628

    Ac-LEHD-pNa

    Caspase 9 substrate.

    ≥95%
  • P1200

    PD-184352

    MEK1/2 and Raf inhibitor.

    ≥98%
  • C4533

    Clindamycin Phosphate

    Lincosamide; ribosomal translocation and protei...

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2026 LKT Laboratories, All Rights Reserved - Products for research use only